Xin Du

机构：University of Science and Technology of China, Guangdong General Hospital, Chinese PLA General Hospital, Ministry of Science and Technology, Guangdong Academy of Medical Sciences · ORCID：0000-0002-9004-8758

发表论文 647 篇 · 总被引 6158 次 · h-index 39

代表论文

• Influenza vaccination to improve outcomes for patients with acute heart failure (PANDA II): a multiregional, seasonal, hospital-based, cluster-randomised, controlled trial in China (2025 · The Lancet · 被引 23)
• Challenges for Chinese innovative cancer drugs in going global: insights from multiregional clinical trials (2025 · The Lancet Oncology · 被引 5)
• Nicolau Syndrome following Benzathine Benzylpenicillin Injection in a Patient with Syphilis and Type 2 Diabetes: A Case Report (2025 · Case Reports in Dermatology · 被引 3)
• Patient-reported outcomes with belantamab mafodotin, pomalidomide, and dexamethasone versus bortezomib, pomalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-8): a phase 3, open-label, randomised controlled trial (2025 · The Lancet Haematology · 被引 3)
• Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myeloma (2025 · Experimental Hematology and Oncology · 被引 3)
• CD33 KO -CD33-mesothelin Loop CAR design avoids fratricide and improves efficacy of iNK cells against acute myeloid leukemia (2025 · Journal for ImmunoTherapy of Cancer · 被引 3)